Nasdaq
Genetic Technologies Gets Nasdaq Delisting Warning
The Australian genomic testing company said that its American Depositary Shares have failed to meet the Nasdaq's minimum bid price requirement for continued listing.
Centogene Regains Compliance With Nasdaq Listing Requirements
The company had already regained compliance with Nasdaq's requirements once before this year, after missing the minimum bid price requirement last December.
Centogene Receives Noncompliance Notice From Nasdaq Over Market Value of Shares
The market value of the company's publicly held shares has fallen below $15 million for 30 consecutive business days, triggering the notification.
Genetron Health Receives Nasdaq Noncompliance Notice
The Chinese cancer molecular profiling company has 180 calendar days, or until Nov. 13, to regain compliance with the Nasdaq minimum bid price requirement.
GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement
The company executed a reverse stock split this month after its share price had languished below $1.00 since November.
May 5, 2023
Trinity Biotech Regains Nasdaq Compliance
Apr 28, 2023
Centogene Receives Nasdaq Noncompliance Notice
Apr 28, 2023
GeneDx to Execute 1-for-33 Reverse Stock Split
Jan 23, 2023
AnPac Bio Receives Nasdaq Delisting Notice
Dec 19, 2022
Centogene Gets Nasdaq Non-Compliance Notice
Sep 27, 2022
AnPac Bio Inks Deal for $3.7M Investment
Sep 12, 2022
AnPac Bio Receives Nasdaq Delisting Determination
Aug 30, 2022
T2 Biosystems Regains Nasdaq Listing Requirements
Mar 28, 2022